Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-08
2007-05-08
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S557000
Reexamination Certificate
active
10505805
ABSTRACT:
Described herein are antipyschotic compounds of formula (I)wherein,A is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, O, and S;Alk is (C1-4) alkylene optionally substituted with OH, methoxy, ethoxy, or F;Ar is optionally substituted phenyl, naphthyl, monocyclic heteroaromatic, or bicyclic heteroaromatic;R1is hydrogen or (C1-4) alkyl optionally substituted with OH, OR3, or OCH2CH2OH,wherein R3is (C1-2) alkyl;R2is H, (C1-6) alkyl, halogen, fluorinated (C1-6) alkyl, OR4, SR4, NO2, CN, COR4, CONR5R6, SO2NR5R6, NR5R6, NR5COR4, NR5SO2R4, or optionally substituted phenyl,whereinR4is hydrogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, or optionally substituted phenyl,R5and R6are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl;Z is one or two substituents independently selected from hydrogen, halogen, (C1-6) alkyl, fluorinated (C1-6) alkyl, OR7, SR7, NO2, CN, COR7, CONR8R9, SO2NR8R9, NR8SO2R7, NR8R9, or optionally substituted phenyl,whereinR7is hydrogen, (C1-6) alkyl, fluorinated alkyl, or optionally substituted phenyl,R8and R9are independently hydrogen, (C1-6) alkyl, or optionally substituted phenyl;and salts, solvates, and crystal forms thereof.Also described are the use of the compounds of formula (I) as antagonists of the dopamine D2receptor and as agents for the treatment of psychosis and bipolar disorder, and pharmaceutical formulations of the compounds of formula (I).
REFERENCES:
patent: 3457264 (1969-07-01), Lembo et al.
patent: 4087421 (1978-05-01), Safir et al.
patent: 0 054 416 (1982-06-01), None
patent: 0 354 781 (1990-02-01), None
patent: WO 96 18629 (1996-06-01), None
G.M. Singerman,The Chemistry of Pyrazine and its Derivatives. IX The Pyrazylethylation of Amines, J. Het. Chem., vol. 1, 1964, pp. 151-152.
J. K. Chakrabarti,Effects of Conformationally Restricted 4-Piperazinyl-10H- thienobenzodiazepine Neuroleptics on Central Dopaminergic and Cholinergic Systems, Journal of Medicinal Chemistry, Ameritcan Chemical Society, Washington, US, vol. 25, No. 10, Oct. 1, 1982, pp. 1133-1140.
Aicher Thomas Daniel
Chen Ying
Chen Zhaogen
Faul Margaret Mary
Krushinski, Jr. Joseph Herman
Cleveland, Jr. John A.
Coleman Brenda
Eli Lilly and Company
Titus Robert D.
LandOfFree
Piperazine substituted aryl benzodiazepines and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine substituted aryl benzodiazepines and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine substituted aryl benzodiazepines and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3779019